Age as a determinant of instability of serum lithium concentrations

Therapeutic Drug Monitoring

Volumn 35, Issue 5, 2013, Pages 643-648

  Van Melick, Els J M ^a   Souverein, Patrick C ^b   Den Breeijen, Johanneke H ^b,c   Tusveld, Charlotte E ^d   Egberts, Toine C G ^b,c   Wilting, Ingeborg ^c  

^a Harbour Hospital   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

affective disorders; elderly; lithium; serum lithium concentration instability; therapeutic drug monitoring

Indexed keywords

ANTICOAGULANT AGENT; LITHIUM;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; DRUG MONITORING; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; HUMAN TISSUE; INTERNATIONAL NORMALIZED RATIO; LITHIUM BLOOD LEVEL; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TITRIMETRY;

ADULT; AGE FACTORS; AGED; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; FEMALE; HUMANS; LITHIUM; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84885020678     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31828f017d     Document Type: Article

References (22)

1. Schou M, Juel-Nielsen N, Strömgren E, et al. The treatment of manic psychosis by the administration of lithium salts. J Neurol Neurosurg Psychiatry. 1954;17:250-260
2. Crossley NA, Bauer M. Acceleration and augmentation of antidepressants with lithium for depressive disorders: Two meta-Analyses of randomized placebo-controlled trials. J Clin Psychiatry. 2007;68:935-940
3. ten Have M, Vollebergh W, Bijl R, et al. Bipolar disorder in the general population in The Netherlands (prevalence, consequences and care utilisation): Results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). J Affect Disord. 2002;68:203-213
4. Amdisen A. Serum concentration and clinical supervision in monitoring of lithium treatment. Ther Drug Monit. 1980;2:73-83
5. Adityanjee, Munshi KR, Thampy A. The syndrome of irreversible lithiumeffectuated neurotoxicity. Clin Neuropharmacol. 2005;28:38-49
6. Nolen WA, Kupka RW, Schulte PFJ, et al. Richtlijn bipolaire stoornissen/ Richtlijncommissie Kwaliteitszorg Van De Nederlandse Vereniging voor Psychiatrie. 2nd Revised Version. Utrecht, The Netherlands: De Tijdstroom; 2008:110
7. British National Formulary. BMJ Group and RPS Publishing. Available at: Www.bnf.org.uk. Accessed May 20, 2010
8. Severus WE, Kleindienst N, Seemüller F, et al. What is the optimal serum lithium level in the long-Term treatment of bipolar disorder-A review? Bipolar Disord. 2008;10:231-237
9. Ng F, Mammen OK, Wilting I, et al. International Society for Bipolar Disorders. The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord. 2009;11:559-595
10. Sproule BA, Hardy BG, Shulman KI. Differential pharmacokinetics of lithium in elderly patients. Drugs Aging. 2000;16:165-177
11. Juurlink DN, Mamdani MM, Kopp A, et al. Drug-induced lithium toxicity in the elderly: A population-based study. J Am Geriatr Soc. 2004;52: 794-798
12. Wilting I, Movig KLL, Moolenaar M, et al. Drug-drug interactions as a determinant of elevated lithium serum levels in daily clinical practice. Bipolar Disord. 2005;7:274-280
13. Aziz R, Lorberg B, Tampi RR. Treatment for late-life bipolar disorder. Am J Geriatr Pharmacother. 2006;4:347-364
14. Leeuwen van Y, Rosendaal FR, Cannegieter SC. Prediction of hemorrhagic and thrombotic events in patients with mechanical heart valve prostheses treated with oral anticoagulants. J Thromb Haemost. 2008; 6:451-456
15. Rosendaal FR, Cannegieter SC, Meer Van Der FJM, et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69:236-239
16. Rose AJ, Hylek EM, Ash AS, et al. Patient characteristics associated with oral anticoagulation control: Results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA). J Thromb Haemost. 2010;8:2182-2191
17. Witt DM, Delate T, Clark NP, et al. Outcomes and predictors of very stable INR control during chronic anticoagulation therapy. Blood. 2009; 114:952-956
18. Head L, Dening T. Lithium in the over-65s: Who is taking it and who is monitoring it? A survey of older adults on lithium in the Cambridge Mental Health Services catchment area. Int J Geriatr Psychiatry. 1998; 13:164-171
19. Fahy S, Lawlor B. Lithium use in octogenarians. Int J Geriatr Psychiatry. 2001;16:1000-1003
20. Paton C, Barnes TRE, Shingleton-Smith A, et al. Lithium in bipolar and other affective disorders: Prescribing practice in the UK. J Psychopharmacol. 2010;24:1739-1746
21. Aronson JK, Reynolds DJM. Lithium. BMJ. 1992;305:1273-1276
22. Melick van EJM, Wilting I, Souvereins PC, et al. Differences in lithium use patterns in the Netherlands; comparing middle aged and older patients, a database study. Am J Geriatr Pharmacother. 2012;10:193-200